Skip to main content
Premium Trial:

Request an Annual Quote

SRU Biosystems, Corning, Williams College, NSF, Altana, Thermo, Bruker, Roentec, Princeton Gamma-Tech


Court Finds SRU Biosystems Infringed Optical Biosensors IP Licensed to Corning

The United States District Court for the District of Delaware found that SRU Biosystems has infringed a US patent exclusively licensed to Corning, Corning said last week.

The patent, No. 4,815,843, covers optical biosensors that enable label-independent detection of chemical, biochemical and biological substances in a sample, Corning said. It was licensed from Artificial Sensing Instruments of Zurich, Switzerland.

Corning, in conjunction with ASI, filed a lawsuit in July 2003 to terminate SRU's infringement.

In addition to declaring SRU's infringement, the US District Court also found that SRU had induced infringement through its testing activities with a potential partner.

Details were not disclosed.

Williams College to Build DNA Facility With $146K NSF Grant

The National Science Foundation has awarded $145,924 to Williams College to establish a laboratory to collect DNA-sequence and genotype data, the university said last week.

The new laboratory will include a capillary-based DNA analyzer, equipment for template amplification and purification, and computer workstations equipped with data-analysis software, according to the Williamstown, Mass.-based university.

The laboratory will be established under the direction of Jason Wilder, an assistant professor of biology at Williams who is studying the forces that shape patterns of genetic variability in nature.

"With this equipment, we'll be able to incorporate acquisition of DNA data directly into the curriculum at Williams, and include these data more efficiently in faculty research," said Wilder.

Altana to Install Thermo's CRS Dimension4 Screening System

Altana Pharma will install a CRS Dimension4 screening system from Thermo Electron, Thermo said last week.

The instrument integrates other Thermo equipment such as Multidrop liquid dispensers and vertical array loaders and Thermo's Cytomat incubators.

At present, Altana screens as many as 80,000 compounds per day, but following the integration of the CRS Dimension4 System the company anticipates screening more than 180,000 compound tests per day.

Financial details were not disclosed.

Bruker, Closing Roentec and Princeton Gamma-Tech Acquisitions, Builds Microanalysis Unit

Bruker AXS last week closed its previously announced acquisition of Roentec and Princeton Gamma-Tech, and has formed a new microanalysis business unit, Bruker AXS Microanalysis.

Financial details of the transactions remain undisclosed.

Bruker said the intent of the acquisitions and the formation of the new unit is to stake a place in the "$150 million" X-ray microanalysis market. Both Roentec and PGT specialize in X-ray detector instruments.

In addition, Bruker's new unit will retain members of the acquired companies' management teams. Roentec's Thomas Schuelein has been named vice president for microanalysis and PGT's Douglas Skinner has been appointed assistant vice president of the new unit, Bruker said.

Note to Subscribers: Because of the Thanksgiving holiday in the US, Cell-Based Assay News will publish next week on Wednesday, Nov. 23. We will resume our normal publishing schedule on Friday, Dec. 2.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.